INTRODUCTION: Electroconvulsive therapy (ECT) is a well-established psychiatric treatment in which @entity410 are electrically induced in @entity1 for therapeutic effects. ECT can produce severe disturbances in the cardiovascular system and a marked increase in cerebral blood flow and intracranial pressure. These cardiovascular changes may be altered using various anesthetic drugs. AIM AND OBJECTIVES: This study was undertaken to compare the effects of intravenous (IV) @entity19014 , @entity1875 , and @entity4671 , used as IV anesthetic agents in modified ECT as regards, induction time and quality of anesthesia, alteration of hemodynamics, @entity410 duration, and recovery time. MATERIALS AND METHODS: A total of 90 @entity1 in the age group of 16-60 years of either sex, who had to undergo ECT therapy were divided randomly into three equal groups. Group A received @entity1875 1% - 1.5 mg/Kg, Group B received @entity4671 - 0.2 mg/Kg, and Group C received @entity4490 2.5% - 5 mg/Kg. All the @entity1 were monitored for changes in heart rate, systolic blood pressure, diastolic blood pressure, and @entity26 saturation at basal, after induction and 1 @entity1009 min, 10 min, 20 min, and 30 min following ECT. Quality of anesthesia, @entity410 duration, and recovery times were also recorded. CONCLUSION: We found that @entity1875 had the advantage of smooth induction, stable hemodynamic parameters and rapid recovery as compared to @entity4671 and @entity4490 . @entity4490 had the advantage over @entity1875 of having longer @entity410 duration at the cost of a relatively prolonged recovery period. @entity4671 had a definite advantage of longer @entity410 duration.

Effectiveness of @entity19014 , @entity1875 , and XXXX as an ideal intravenous anesthetic agent for modified electroconvulsive therapy.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity410 :: ('MESH:D012640', 'Disease') :: ['seizure', 'seizures'] @entity1009 :: ('966', 'Gene') :: ['min, 2 min, 3 min, 5'] @entity26 :: ('MESH:D010100', 'Chemical') :: ['oxygen'] @entity4490 :: ('MESH:D013874', 'Chemical') :: ['thiopentone', 'Thiopentone'] @entity1875 :: ('MESH:D015742', 'Chemical') :: ['propofol'] @entity4671 :: ('MESH:D005045', 'Chemical') :: ['etomidate', 'Etomidate'] @entity19014 :: ('CHEBI:9561', 'Chemical') :: ['sodium thiopentone']
@entity4671 :: (MESH:D005045,Chemical) :: ['etomidate']
